Nautilus Biotechnology Statistics Share Statistics Nautilus Biotechnology has 126.31M
shares outstanding. The number of shares has increased by 0.59%
in one year.
Shares Outstanding 126.31M Shares Change (YoY) 0.59% Shares Change (QoQ) 0% Owned by Institutions (%) 50.25% Shares Floating 51.28M Failed to Deliver (FTD) Shares 59 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 175.23K, so 0.14% of the outstanding
shares have been sold short.
Short Interest 175.23K Short % of Shares Out 0.14% Short % of Float 0.42% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.98 and the forward
PE ratio is -1.25.
Nautilus Biotechnology's PEG ratio is
-0.3.
PE Ratio -2.98 Forward PE -1.25 PS Ratio 0 Forward PS 41.9 PB Ratio 1.01 P/FCF Ratio -3.44 PEG Ratio -0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Nautilus Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 17.4,
with a Debt / Equity ratio of 0.15.
Current Ratio 17.4 Quick Ratio 17.4 Debt / Equity 0.15 Debt / EBITDA -0.47 Debt / FCF -0.5 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-528.21K Employee Count 134 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -71.48% in the
last 52 weeks. The beta is 1.24, so Nautilus Biotechnology's
price volatility has been higher than the market average.
Beta 1.24 52-Week Price Change -71.48% 50-Day Moving Average 0.72 200-Day Moving Average 1.06 Relative Strength Index (RSI) 65.37 Average Volume (20 Days) 349,674
Income Statement
Revenue n/a Gross Profit -6.35M Operating Income -81.48M Net Income -70.78M EBITDA -64.43M EBIT -70.78M Earnings Per Share (EPS) -0.56
Full Income Statement Balance Sheet The company has 27.65M in cash and 30.48M in
debt, giving a net cash position of -2.83M.
Cash & Cash Equivalents 27.65M Total Debt 30.48M Net Cash -2.83M Retained Earnings -273.02M Total Assets 213.19M Working Capital 142.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.15M
and capital expenditures -2.12M, giving a free cash flow of -61.27M.
Operating Cash Flow -59.15M Capital Expenditures -2.12M Free Cash Flow -61.27M FCF Per Share -0.49
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
